VHB Lifesciences
VHB Lifesciences VHB Lifesciences
VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences
VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences
VHB Lifesciences
api
VHB Lifesciences
VHB Lifesciences
Formulation
VHB Lifesciences
VHB Lifesciences
Field Force
VHB Lifesciences
VHB Lifesciences
VHB Lifesciences
Home » Product Index » Marketing Division » Proton
« Previous  1 | 2 | 3 | 4 | 5 | 6 | 7 | 8  Next »

Proton

We supply variety of amifostine injection, cyclophosphamide injection, docetaxel injection, carboplatin injection, thioguanine tablets etc.

DETAXL

DETAXL Generic Name :  DOCETAXL

Packing :  single dose vial with solvent

Indication & Dosage :
Breast cancer: 100 mg/m2 IV on day 1.Repeat cycles every 21 days for a total of 4 cycles as a part of ACT regimen
Non–small cell lung cancer: 75 mg/m2 IV on day 1.Repeat cycles every 21 days for a total of 4 cycles as a part of DOCETAXEL + CARBOPLATIN regimen

Therapeutic Segement :
Taxane, Antimicrotubule agent

Our Brand Name :
DETAXL

Strength :
20mg/0.5ml ,80mg/2ml ,120/3ml

CARBOPLATIN

CARBOPLATIN Generic Name :  CARBOPLATIN

Packing :  single vial

Indication & Dosage :
Ovarian Cancer: AUC of 6-7.5 , IV on day 1.Repeat cycle every 28 days as a part of CC protocol.
Head & Neck Cancer: AUC of 6, IV on day 1.Repeat cycle every 21-28 days as a part of TIC protocol.
Non–small cell lung cancer : AUC of 6, IV on day 1.Repeat cycle every 28 days for 4 cycles as a part of TC protocol.
Small cell lung cancer : AUC of 6, IV on day 1.Repeat cycle every 28 days as a part of EC protocol.
Bladder Cancer: AUC of 6, IV on day 1 given 15 minutes after paclitaxel as a part of TC protocol

Therapeutic Segement :
Platinum analog

Our Brand Name :
CARBOTEEN

Strength :
150mg/15ml, 450mg/45ml

6-TG

6-TG Generic Name :  6-Thioguanine

Packing :  10 BLISTERS OF 10 TABLETS

Indication & Dosage :
Acute myelogenous leukemia
Acute lymphoblastic leukemia
Chronic myelogenous leukemia

1.Induction: 100 mg/m2 PO every 12 hours on days 1–5, usually in combination with cytarabine
2.Maintenance: 100 mg/m2 PO every 12 hours on days 1–5, every four weeks, usually in combination with other agents.
3.Single-agent: 1–3 mg/kg PO daily.

Therapeutic Segement :
Antimetabolite

Our Brand Name :
6-TG

Strength :
40mg

HI-TREX

HI-TREX Generic Name :  Methotrexate

Packing :  Inj.SINGLE VIAL & Tab:10 STRIP OF 10 TABLETS

Indication & Dosage :
Breast cancer.
Head and neck cancer
Osteogenic sarcoma.
Acute lymphoblastic leukemia
Non-Hodgkin's lymphoma.
Meningeal leukemia and carcinomatous meningitis
Bladder cancer.
Colorectal cancer
Gestational trophoblastic cancer.

1.Low dose: 10–50 mg/m2 IV every 3–4 weeks.
2.Low dose weekly: 25 mg/m2 IV weekly.
3.Moderate dose: 100–500 mg/m2 IV every 2–3 weeks.
4.High dose: 1–12 gm/m2 IV over a 3- to 24-hour period every 1–3 weeks.
5.Intrathecal: 10–15 mg IT 2 times weekly until CSF is clear, then weekly dose for 2–6 weeks, followed by monthly dose.
6.Intramuscular: 25 mg/m2 IM every three weeks.

Therapeutic Segement :
Antimetabolite

Our Brand Name :
HI-TREX

Strength:
Inj.50MG/2ML, 2.5MG tab.

AMFOS

AMFOS Generic Name :  Amifostine

Packing :  single lyophilized vial

Indication & Dosage :
Reduce the incidence of nephrotoxicity in patients with ovarian cancer and non-small cell lung cancer receiving cisplatin-based chemotherapy.
Reduce the incidence of moderate to severe xerostomia in patients undergoing postoperative radiation treatment for head and neck cancer, where the radiation port includes a significant portion of the parotid glands.

1.Recommended dose for reduction of cumulative renal toxicity is 910 mg/m2 IV, administered once daily 30 minutes before cisplatin chemotherapy.
2.Recommended dose for reduction of xerostomia is 200 mg/m2 administered once daily 15–30 minutes before radiation therapy.
3.Alternative regimen for head and neck cancer patients is 500 mg SC administered once daily 20 minutes before radiation therapy.

Therapeutic Segement :
Organic thiophosphate analog

Our Brand Name :
AMFOS

Strength :
500MG

CYCRAME

CYCRAME Generic Name :  Cyclophosphamide

Packing :  single vial

Indication & Dosage :
1. Breast cancer: When given orally, the usual dose is 100 mg/m2 PO on days 1–14 given every 28 days. When administered IV, the usual dose is 600 mg/m2 given every 21 days as part of the AC or CMF regimens.
2. Non-Hodgkin's lymphoma: Usual dose is 400–600 mg/m2 IV on day one every 21 days, as part of the CVP regimen, and 750 mg/m2 on day one every 21 days, as part of the CHOP regimen.
3. High-dose bone marrow transplantation: Usual dose in the setting of bone marrow transplantation is 60 mg/kg IV for two days.

Therapeutic Segement:
Alkylating agent

Our Brand Name :
CYCRAME

Strength :
200mg, 500mg, 1gm

PROCARB

PROCARB Generic Name :  Procarbazine

Packing :  5 STRIP OF 10 CAPSULES

Indication & Dosage :
Hodgkin's disease: 100 mg/m2 PO daily for 14 days, as part of MOPP regimen
Brain tumors: 60 mg/m2 PO daily for 14 days, as part of PCV regimen

Therapeutic Segement :
Nonclassic alkylating agent

Our Brand Name :
PROCARB

Strength :
50 mg

HEPABIG

HEPABIG Generic Name :  Hepatitis-B Immuno Globulin

Packing :  SINGLE VIAL

Indication & Dosage :
Liver Transplantation: 10,000 IU during anhepatic phase and daily administration of 10,000 IU during the first week of post LT followed by 10,000 IU on monthly basis.

Perinatal Transmission: For neonates born to HbsAg positive mothers is 200 IU within 12 hours of birth, preferably within 48 hours of birth.

Needle prick injury : PEP* dose in adults is 12 IU/kg of body weight. (within 7 days preferably within 48 hours).

Leukemia/Lymphoma: 40 IU/kg for five months along with vaccination in Leukemia / Lymphoma patients followed by booster dose in 12th month.

Therapeutic Segement :
Immunoglobulin

Our Brand Name :
HEPABIG

Strength :
200 I.U.